Changing needs of the patient with diabetes mellitus during the teenage years

Current Opinion in Pediatrics

Volumn 8, Issue 4, 1996, Pages 319-327

  Gordon, Catherine M ^a   Mansfield, M Joan ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOTRIMAZOLE; DESOGESTREL; FLUCONAZOLE; GESTAGEN; GESTODENE; INSULIN; INSULIN ZINC SUSPENSION; ISOPHANE INSULIN; LEVONORGESTREL; MEDROXYPROGESTERONE; MICONAZOLE; NORETHISTERONE; NORGESTIMATE; ORAL CONTRACEPTIVE AGENT; TERCONAZOLE;

ADOLESCENT; ANOREXIA NERVOSA; BLOOD GLUCOSE MONITORING; BULIMIA; CLINICAL TRIAL; CONTRACEPTION; DIABETES MELLITUS; DIABETIC DIET; DIABETIC RETINOPATHY; FAMILY; FEEDING DISORDER; HOME CARE; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN TREATMENT; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; REVIEW; SELF ESTEEM; VAGINA CANDIDIASIS;

EID: 0029852817     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-199608000-00004     Document Type: Review

References (51)

1. American Diabetes Association: Diabetes 1993 Vital Statistics. Alexandria, VA: American Diabetes Association Diabetes Information Center; 1993.
2. Wise J, Kolb E, Sauder S: Effect of glycemic control on growth velocity in children with IDDM. Diabetes Care 1992, 15:826-830.
3. Diabetes Control and Complications Trial Research Group: Diabetes Control and Complications Trial (DCCT): the effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:977-986.
4. DCCT Research Group: Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus. J Pediatr 1994, 125:177-188.
5. Jacobson AM, Hauser ST, Wolfsdorf JI, Houlihan J, Milley JE, Herskowitz RD: Psychologic predictors of compliance in children with recent onset of diabetes mellitus. J Pediatr 1987, 110:805-811.
6. Hanson CL, Deguire MJ, Schinkel AM, Kolterman OG: Empirical validation for a family-centered model of care. Diabetes Care 1995, 18:1347-1356. Glycohemoglobin levels of 157 adolescents with IDDM, aged 12 to 20 years, were evaluated, along with treatment adherence and psychosocial family data, through interviews and self-reports. A family-centered model for IDDM care is analyzed with a structural modeling statistical program. As expected, this approach to diabetes care appears to facilitate positive family functioning, reduces stress, and may promote improved metabolic control.
7. Grey M, Cameron ME, Lipman TH, Thurber FW: Psychosocial status of children with diabetes in the first two years after diagnosis. Diabetes Care 1995, 18:1330-1336. Eighty-nine patients with IDDM were compared with 53 children without the disease to determine the pattern of adjustment over time. The age range of the children was 8 to 14 years. Psychosocial status was assessed using several psychologic and behavioral testing instruments. Two years after the diagnosis, depression, dependency, and withdrawal were significantly more common in children with diabetes than in their peers without the disease. The 2 years following diagnosis are presented as a critical period for the acquisition of adaptation skills and a time for health care providers to be vigilant for the exacerbation of psychosocial concerns.
8. Weissberg-Benchell J, Wirtz P, Glasgow AM, Turek J, Tynan WD, Ward J: Adolescent diabetes: management and mismanagement Diabetes Care 1995, 18:77-82. A fascinating study that stresses the importance of recognizing the prevalence of diabetes mismanagement among adolescent patients. A total of 144 adolescent IDDM patients, aged 11 to 19 years, completed a confidential questionnaire, and glycohemoglobin levels were measured. Questionnaires were also completed by a group of 55 parents who were asked to predict the responses of their children. Additionally, 56 pediatric endocrinologists were asked to estimate the frequency of mismanagement behavior among adolescents in their practice. Both parents and the physicians were found to underestimate the frequency with which teenagers engage in a variety of mismanagement behaviors. Teens were found to fabricate blood test results because of perceived pressure from their family and physicians to produce good results.
9. Spack NP: Diabetes mellitus in adolescents. Adolesc Med 1991, 2:523-538.
10. Hanson CL, Rodrigue JR, Henggler SW, Harris MA, Kleges RC, Carle DL: The perceived self-competence of adolescents with insulin-dependent diabetes mellitus. J Pediatr Psychol 1990, 15:605-618.
11. Ireys HT, Gross SS, Werthamer-Larsson LA, Koldner KB: Self-esteem of young adults with chronic health conditions: appraising the effects of perceived impact. J Dev Behav Pediatr 1994, 15:409-415.
12. Amiel SA, Sherwin RS, Simonson DC, Lauritano AA, Tamborlane WV: Impaired insulin action in puberty: a contributing factor to poor glycemic control in adolescents. N Engl J Med 1966, 31:215-216.
13. Caprio S, Plewe G, Diamond MP, Simonson DC, Boulware SD, Sherwin RS, Tamborlane WV: Increased insulin secretion in puberty: a compensatory response to reductions in insulin sensitivity. J Pediatr 1989, 114:963-967.
14. Caprio S, Cline G, Boulware SD, Permanente C, Shulman GI, Sherwin RS, Tamborlane WV: Effects of puberty and diabetes on insulin-sensitive fuels. Am J Physiol 1994, 266:885-891.
15. Rother KI, Levitsky LL: Diabetes mellitus during adolescence. Endocrinol Meab Clin North Am 1993, 22:553-772.
16. Bloch CA, Clemmons P, Sperling MA: Puberty reduces insulin sensitivity. J Pediatr 1987, 110:481-487.
17. Edge JA, Dunger DB, Matthews DR, Gilbert JP, Smith CP: Increased overnight growth hormone concentrations in diabetic compared with normal adolescents. J Clin Endocrinol Metab 1990, 71:1356-1362.
18. Du Caju MVL, Rooman RP, De Beeck LO: Longitudinal data on growth and final height in diabetic children. Pediatr Res 1995, 38:607-611. A longitudinal study documenting height, weight, skeletal age, and pubertal development in 46 children from initial diagnosis of IDDM until the attainment of final height. The study provides more reliable data than previous studies on this subject utilizing a cross-sectional design. Surprisingly, unlike other studies, no correlation was found between growth and metabolic control.
19. Jackson RL: Growth and maturation of children with insulin-dependent diabetes mellitus. Pediatr Clin North Am 1984, 31:545-567.
20. Schmidt L, Colby P, Kwong C: Practical nutritional guidelines to reduce the risk of hypoglycemia in patients treated with insulin. Clin Diabetes 1995, 13:46-48. Guidelines for encouraging adherence to intensive insulin regimens are presented.
21. Cryer P, Fisher J, Shannon H: Hypoglycemia. Diabetes Care 1994, 17:734-755.
22. Frank RN, Hoffman WH, Podgor MJ, Joondeph HC, Lewis RA, Margherio RR, Nachazel DP Jr, Weiss H, Christopherson KW, Cronin MA: Retinopathy in juvenile-onset type 1 diabetes of short duration. Diabetes 1982, 31:874-882.
23. Kostraba JN, Dorman JS, Orchard TJ, Becker DJ, Ohki Y, Ellis D, Doft BH, Lobes LA, LaPorte RE, Drash AL: Contributions of diabetes duration before puberty to development of microvascular complications in IDDM subjects. Diabetes Care 1989, 12:686-693.
24. Boyle PJ, Kempers SF, O'Connor AM, Nagy RJ: Brain glucose uptake and unawareness of hypoglycemic in patients with insulin-dependent diabetes mellitus. N Engl J Med 1995, 333:1726-1731. An interesting study that postulates that accelerated transport of glucose to the brain is a mechanism of unawareness of hypoglycemia in patients with IDDM. Brain glucose uptake was measured in 24 IDDM patients at normal and hypoglycemic plasma levels and compared with uptake in 15 normal subjects at these experimental parameters. There was no significant difference in brain glucose uptake in patients with the lowest glycosylated hemoglobin values. The responses of plasma epinephrine and pancreatic polypeptide levels as well as symptoms of hypoglycemia were lowest in the group with the lowest glycosylated hemoglobin values.
25. Wolfsdorf JI, Laffel LMB: Diabetes in childhood: predicting the future. Pediatr Ann 1994, 23:306-312.
26. 1c of 8.1%). This study provides a specific target to guide attempts to reduce the frequency of diabetic nephropathy.
27. 1c value below 8.1% appears to reduce the risk of retinopathy achievable by improving glycemic control, while minimizing adverse effects from hypoglycemia.
28. Danne T, Weber B, Hartmann R, Enders I, Burger W, Hovener G: Long-term glycemic control has a nonlinear association to the frequency of background retinopathy in adolescents with diabetes. Diabetes Care 1994, 17:1390-1396.
29. McKenna MJ, Herskowitz R, Wolfsdorf JI: Screening for thyroid disease in children with IDDM. Diabetes Care 1990, 13:801-803.
30. Delhanty L, Halford B: The role of diet behaviors in achieving glycemic control in intensively treated patients in the Diabetes Control and Complications Trial. Diabetes Care 1993, 16:1453-1458.
31. Anderson EJ, Richardson M, Castle G, Cereone S, Delhanty L, Lyon R, Mueller D, Snetselaar L: Nutritional interventions for intensive therapy in the Diabetes Control and Complications Trial. J Am Diet Assoc 1993, 93:768-772.
32. American Diabetes Association: Clinical practice recommendations 1996: nutrition recommendations and principles for people with diabetes mellitus. Diabetes Care 1996, 19:S16-S19.
33. Pickup JC: Sampling and sensing blood glucose. Lancet 1993, 342:1068.
34. Robinson MR, Eaton RP, Haaland DM, Koepp GW, Thomas EV, Stallard BR, Robinson PL: Noninvasive glucose monitoring in diabetic patients: a preliminary evaluation. Clin Chem 1992, 38:1618-1622.
35. Muhlhauser I: Smoking and diabetes. Diabet Med 1990, 7:10-14.
36. Hansotia P, Broste SK: The effect of epilepsy or diabetes mellitus on the risk of automobile accidents. N Engl J Med 1991, 324:22-26.
37. Polonsky WH, Anderson BJ, Lohrer PA, Aponte JE, Jacobson AM, Cole CF: Insulin omission in women with IDDM. Diabetes Care 1994, 17:1178-1185.
38. Biggs MM, Basco MR, Patterson G, Raskin P: Insulin withholding for weight control in women with diabetes. Diabetes Care 1994, 17:1186-1189.
39. Rodin GM, Daneman D: Eating disorders and IDDM: a problematic association. Diabetes Care 1992, 15:1402-1412.
40. Pollock M, Kovacs M, Charron-Prochownik D: Eating disorders and maladaptive dietary/insulin management among youths with childhood onset insulin-dependent diabetes mellitus. J Am Acad Child Adolesc Psychiatry 1995, 34:291-296. Forty-three girls and 35 boys, aged 8 to 13 years at IDDM onset, were followed up to determine the prevalence of DSM-III eating disorders and symptoms of maladaptive dietary or insulin management and their psychiatric and biomedical correlates. By a mean age of 21 years, 3.8% had DSM-III eating disorders and 11.4% had "eating problems," exhibiting severe dietary indiscretion and repeated insulin omission. Youth with "eating problems" were nine times more likely to have had a psychiatric disorder than the rest of the patients and had a significantly higher rate of medical noncompliance. Patients who exhibit serious dietary indiscretion and repeated insulin omission appear to have other psychiatric problems as well.
41. Mueller C, Field T, Yando R, Harding J, Gonzalez KP, Lasko D, Bendell D: Under-eating and over-eating concerns among adolescents. J Child Psychol Psychiatry 1995, 36:1019-1025. A total of 462 adolescent high school students were given a set of scales to determine their concerns about eating and perceptions of family and peer intimacy, social support, self-esteem, depression, and exercise. Fifty percent of the sample claimed to have concerns about undereating or overeating. Both groups had low self-esteem scores. The group concerned about overeating also scored higher on the depression scale.
42. Widom B, Diamond MP, Simonson DC: Alterations in glucose metabolism during menstrual cycle in women with IDDM. Diabetes Care 1992, 15:213-220.
43. Cawood EHH, Bancroft J, Steel JM: Perimenstrual symptoms in women with diabetes mellitus and the relationship to diabetic control. Diabet Med 1993, 10:444-448.
44. Klein BEK, Moss SE, Klein R: Oral contraceptives in women with diabetes. Diabetes Care 1990, 13:1099-1102.
45. Kjaer K, Hagen C, Sando SH, Eshoj O: Epidemiology of menarche and menstrual disturbances in an unselected group of women with insulin dependent diabetes mellitus compared to controls. J Clin Endocrinol Metab 1992, 75:524-529.
46. Peterson KR, Skouby SO, Vedel P, Haaber AB: Hormonal contraception in women with IDDM. Diabetes Care 1995, 18:800-806. The effect of a monophasic combination oral contraceptive on glycemic control and lipoprotein profiles was evaluated in 22 diabetic women. No evidence of impaired metabolic control or of the lipoprotein changes that accompany atherosclerosis was noted in these women with well-controlled IDDM.
47. Garg SK, Chase HP, Marshall G, Hoops SL, Holmes DL, Jackson WE: Oral contraceptives and renal and retinal complications in young women with insulin-dependent diabetes mellitus. JAMA 1994, 271:1099-1102.
48. Mestman JH, Schmidt-Sarosi C: Diabetes mellitus and fertility control: contraception management issues. Am J Obstet Gynecol 1993, 168:2012-2020.
49. World Health Organization: WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception: venous thromboembolic disease and combined oral contraceptives. Results of international multicentre case-control study. Lancet 1995, 346:1575-1582.
50. World Health Organization: WHO Collaborative Study of Thromboembolic Disease and Steroid Hormone Contraception: effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet 1995, 346:1575-1582.
51. Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C: Risk of idiopathic cardiovascular death and nonfatal venous thromoembolism in women using oral contraceptives with differing progestagen components. Lancet 1995, 346:1589-1593.